Market Overview:
The global PCR and RT-PCR enzymes market is expected to reach a value of USD 1,711.8 million by 2030, registering a CAGR of 7.5% during the forecast period (2018-2030). The growth in this market can be attributed to the increasing demand for nucleic acid amplification techniques for various applications such as diagnostics, drug discovery & development, and food testing. Based on type, the global PCR and RT-PCR enzymes market is segmented into DNA polymerase and reverse transcriptase. The DNA polymerase segment is further subsegmented into Taq DNA polymerase, Pfu DNA polymerase, Tth DNA polymerases etc., while the reverse transcriptases are subsegmented into AMV reverse transcriptases etc.
Product Definition:
The polymerase chain reaction (PCR) is a technique used to amplify specific DNA sequences. The PCR enzyme recognizes and binds to the target sequence, then begins replication of the DNA strands. This process is repeated multiple times, resulting in an amplified copy of the target DNA. RT-PCR (reverse transcriptase PCR) uses a reverse transcriptase enzyme to create a complementary strand of RNA from a single stranded DNA template.
DNA Polymerase:
DNA polymerase is an enzyme that adds nucleotides to the growing DNA chain. It is used in PCR (polymerase chain reaction) and reverse transcriptase-PCR (RT-PCR) for the amplification of DNA. The enzyme finds application in molecular biology, forensics, clinical diagnostics, gene expression studies and drug discovery processes.
Reverse Transcriptase:
Reverse transcriptase is an enzyme that catalyzes the conversion of RNA to DNA. It is used in polymerase chain reaction (PCR) and reverse transcription PCR (RT-PCR) for the synthesis of cDNA. The process allows amplification using a single piece of DNA as a primer by using 3' end RNAs as primers.
Isolation & purification steps involved in making RT-PCRs.
Application Insights:
PCR is widely used for the detection of infectious diseases, cancer and other genetic disorders. The presence of multiple PCR products in a sample indicates the occurrence of a disease outbreak and aids in early diagnosis. This factor is anticipated to fuel product demand during the forecast period.
The rising prevalence of chronic diseases such as cancer, diabetes mellitus, autoimmune disorders & neurodegenerative conditions drives demand for rapid diagnostic tests that are sensitive and specific enough to detect genetic mutations associated with these diseases at an early stage using RT-PCR techniques. This application segment accounted for over 50% revenue share in 2015 owing to its wide applications across clinical diagnostics laboratories worldwide including oncology testing centers, hematology laboratories and R&D centers etc. However; increasing adoption rate of next generation sequencing technologies may challenge this trend over the coming years (2016-2030).
Regional Analysis:
North America dominated the market in terms of revenue share in 2016. The dominance can be attributed to factors such as local presence of leading PCR and RT-PCR enzymes manufacturers, availability of advanced diagnostic technologies, and high healthcare expenditure. Moreover, increasing prevalence of cancer is also expected to drive the demand for PCR and RT-PCR enzymes in this region. For instance, according to statistics published by American Cancer Society in 2017; more than 1 million new cases were estimated to be diagnosed by 2020.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing its developing economy coupled with rising awareness regarding early diagnosis among patients suffering from chronic diseases such as cancer & diabetes & cardiovascular disorders etc., which are major drivers for growth during the forecast period from 2017 To 2030 (till 2022).
Growth Factors:
- Increasing demand for PCR and RT-PCR enzymes in the field of molecular biology for research and diagnostic purposes.
- Rising prevalence of target diseases that can be diagnosed through PCR and RT-PCR techniques, such as cancer, tuberculosis, etc.
- Growing number of biotechnology and pharmaceutical companies that are using PCR and RT-PCR enzymes for drug discovery processes.
- Technological advancements in the field of PCR and RT-PCR that are making these techniques more sensitive, specific, and efficient.
Scope Of The Report
Report Attributes
Report Details
Report Title
PCR and RT-PCR Enzymes Market Research Report
By Type
DNA Polymerase, Reverse Transcriptase
By Application
PCR, RT-PCR
By Companies
AAT Bioquest, BLIRT, Geno Technology，Inc., Meridian Life Science，Inc, Ampliqon, Applied Biosystems, Bio-Rad, Takara Bio, Toyobo, Agilent, AAT Bioquest, Biopanda Diagnostics, Bioneer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
184
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global PCR and RT-PCR Enzymes Market Report Segments:
The global PCR and RT-PCR Enzymes market is segmented on the basis of:
Types
DNA Polymerase, Reverse Transcriptase
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
PCR, RT-PCR
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AAT Bioquest
- BLIRT
- Geno Technology，Inc.
- Meridian Life Science，Inc
- Ampliqon
- Applied Biosystems
- Bio-Rad
- Takara Bio
- Toyobo
- Agilent
- AAT Bioquest
- Biopanda Diagnostics
- Bioneer
Highlights of The PCR and RT-PCR Enzymes Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DNA Polymerase
- Reverse Transcriptase
- By Application:
- PCR
- RT-PCR
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the PCR and RT-PCR Enzymes Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
PCR (polymerase chain reaction) is a technique used to amplify specific DNA sequences. RT-PCR (reverse transcription PCR) is a similar technique that uses the reverse transcriptase enzyme to create a copy of the target DNA sequence.
Some of the major companies in the pcr and rt-pcr enzymes market are AAT Bioquest, BLIRT, Geno Technology，Inc., Meridian Life Science，Inc, Ampliqon, Applied Biosystems, Bio-Rad, Takara Bio, Toyobo, Agilent, AAT Bioquest, Biopanda Diagnostics, Bioneer.
The pcr and rt-pcr enzymes market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 PCR and RT-PCR Enzymes Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 PCR and RT-PCR Enzymes Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 PCR and RT-PCR Enzymes Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the PCR and RT-PCR Enzymes Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global PCR and RT-PCR Enzymes Market Size & Forecast, 2018-2028
4.5.1 PCR and RT-PCR Enzymes Market Size and Y-o-Y Growth
4.5.2 PCR and RT-PCR Enzymes Market Absolute $ Opportunity
Chapter 5 Global PCR and RT-PCR Enzymes Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 PCR and RT-PCR Enzymes Market Size Forecast by Type
5.2.1 DNA Polymerase
5.2.2 Reverse Transcriptase
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global PCR and RT-PCR Enzymes Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 PCR and RT-PCR Enzymes Market Size Forecast by Applications
6.2.1 PCR
6.2.2 RT-PCR
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global PCR and RT-PCR Enzymes Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 PCR and RT-PCR Enzymes Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America PCR and RT-PCR Enzymes Analysis and Forecast
9.1 Introduction
9.2 North America PCR and RT-PCR Enzymes Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America PCR and RT-PCR Enzymes Market Size Forecast by Type
9.6.1 DNA Polymerase
9.6.2 Reverse Transcriptase
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America PCR and RT-PCR Enzymes Market Size Forecast by Applications
9.10.1 PCR
9.10.2 RT-PCR
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe PCR and RT-PCR Enzymes Analysis and Forecast
10.1 Introduction
10.2 Europe PCR and RT-PCR Enzymes Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe PCR and RT-PCR Enzymes Market Size Forecast by Type
10.6.1 DNA Polymerase
10.6.2 Reverse Transcriptase
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe PCR and RT-PCR Enzymes Market Size Forecast by Applications
10.10.1 PCR
10.10.2 RT-PCR
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific PCR and RT-PCR Enzymes Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific PCR and RT-PCR Enzymes Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific PCR and RT-PCR Enzymes Market Size Forecast by Type
11.6.1 DNA Polymerase
11.6.2 Reverse Transcriptase
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific PCR and RT-PCR Enzymes Market Size Forecast by Applications
11.10.1 PCR
11.10.2 RT-PCR
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America PCR and RT-PCR Enzymes Analysis and Forecast
12.1 Introduction
12.2 Latin America PCR and RT-PCR Enzymes Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America PCR and RT-PCR Enzymes Market Size Forecast by Type
12.6.1 DNA Polymerase
12.6.2 Reverse Transcriptase
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America PCR and RT-PCR Enzymes Market Size Forecast by Applications
12.10.1 PCR
12.10.2 RT-PCR
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) PCR and RT-PCR Enzymes Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) PCR and RT-PCR Enzymes Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) PCR and RT-PCR Enzymes Market Size Forecast by Type
13.6.1 DNA Polymerase
13.6.2 Reverse Transcriptase
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) PCR and RT-PCR Enzymes Market Size Forecast by Applications
13.10.1 PCR
13.10.2 RT-PCR
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 PCR and RT-PCR Enzymes Market: Competitive Dashboard
14.2 Global PCR and RT-PCR Enzymes Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AAT Bioquest
14.3.2 BLIRT
14.3.3 Geno Technology，Inc.
14.3.4 Meridian Life Science，Inc
14.3.5 Ampliqon
14.3.6 Applied Biosystems
14.3.7 Bio-Rad
14.3.8 Takara Bio
14.3.9 Toyobo
14.3.10 Agilent
14.3.11 AAT Bioquest
14.3.12 Biopanda Diagnostics
14.3.13 Bioneer
